Video

TML data on bevacizumab for colorectal cancer 'validate practice in the community'


 

Community Oncology Editor Dr. Jame Abraham spoke with Dr. George Kim at the Oncology Practice Summit in Las Vegas about the new developments in treating colon and GI cancers.

The Oncology Practice Summit was the 8th annual meeting of Community Oncology, the journal of clinical issues in community practice. Dr. Abraham was a co-chair of the Summit, which was hosted this year by Community Oncology as well as The Journal of Supportive Oncology and The Oncology Report.

Recommended Reading

Racial gap in gastric cancer survival narrows at 3 years
MDedge Hematology and Oncology
Selective resection feasible for esophageal cancer
MDedge Hematology and Oncology
FOLFOXIRI bests FOLFIRI when bevacizumab is added in colorectal cancer
MDedge Hematology and Oncology
Colorectal cancer subtype associated with obesity, inactivity
MDedge Hematology and Oncology
Third drug approved for metastatic, treatment-resistant GIST
MDedge Hematology and Oncology
Everolimus approval now includes prevention of liver transplant rejection
MDedge Hematology and Oncology
Alpha-fetoprotein useful marker in HCC
MDedge Hematology and Oncology
Surgery may be avoided in early rectal cancer
MDedge Hematology and Oncology
New blood test could identify early pancreatic cancer
MDedge Hematology and Oncology
Designer T cells take aim at liver metastases
MDedge Hematology and Oncology

Related Articles